Guardant Health to Participate in the BofA Securities 2021 Healthcare Conference
b'Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the company will be participating in the upcoming BofA Securities 2021 Healthcare Conference.\nGuardant Health\xe2\x80\x99s management is scheduled to participate in a fireside chat on Wednesday, May 12 at 2:00 p.m. Pacific Time / 5:00 p.m. Eastern Time.
- b'Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the company will be participating in the upcoming BofA Securities 2021 Healthcare Conference.\nGuardant Health\xe2\x80\x99s management is scheduled to participate in a fireside chat on Wednesday, May 12 at 2:00 p.m. Pacific Time / 5:00 p.m. Eastern Time.
- The Guardant Health oncology platform leverages capabilities to drive commercial adoption, improve patient clinical outcomes, and lower healthcare costs across all stages of the cancer care continuum.
- Guardant Health has commercially launched liquid biopsy-based Guardant360\xc2\xae, Guardant360 CDx, and GuardantOMNI\xc2\xae tests for advanced stage cancer patients, and Guardant Reveal\xe2\x84\xa2 test for early-stage cancer patients.
- These tests fuel development of its LUNAR screening program, which aims to address the needs of asymptomatic individuals eligible for cancer screening and individuals at a higher risk for developing cancer with early detection.\n'